Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
about
Recent Developments in Cellular Immunotherapy for HSCT-Associated ComplicationsImmunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapyTherapeutic effect of human adipose-derived stem cells and their secretome in experimental diabetic pain.Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophagesNanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine.Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype.Mesenchymal Stem Cell-Derived Exosomes: Immunomodulatory Evaluation in an Antigen-Induced Synovitis Porcine Model.Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease.Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes.Biodistribution and Immunogenicity of Allogeneic Mesenchymal Stem Cells in a Rat Model of Intraarticular Chondrocyte Xenotransplantation.Challenges in vascular tissue engineering for diabetic patients.Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma.Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice.Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering
P2860
Q28079823-44182E9B-02D1-4ECE-A0D7-F23B1EE678DEQ29994669-BA70F961-4170-4EC1-A69B-E54409C4B164Q38603054-F5359B82-E87C-4476-BB8F-D70DA2B31DA4Q38607615-C9F7487D-00FF-403A-9A5F-70983801F330Q39044765-0E08BB25-D08A-478F-8F7D-70380A924248Q42030296-B02F22D9-6A7F-4011-8B0A-3FE2BE98461BQ42111141-9F669D40-EC49-4CD9-862A-16CE8629E110Q42211281-D493B5A9-0BAC-496C-B125-14BCEE5479F6Q42392488-B201827D-058D-4AF2-97D3-FB7FDB4787D6Q47123674-A2ED2E62-BB2D-499F-B03B-1F558BD3ACC2Q49361293-E7EF5F60-4AA6-464F-873A-2F94D4EE86BFQ55031358-584B5AC4-53B0-49D2-963D-47DB0306C71EQ55257378-74D8D705-ED46-477D-9AA5-DFC3A658181DQ58766184-E703A3C5-861F-4A7E-97FF-121A31082C29
P2860
Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
@ast
Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
@en
Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
@nl
type
label
Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
@ast
Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
@en
Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
@nl
prefLabel
Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
@ast
Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
@en
Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
@nl
P2860
P3181
P356
P1476
Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
@en
P2093
Martin J Hoogduijn
Samantha F H de Witte
P2860
P3181
P356
10.3389/FIMMU.2015.00648
P407
P577
2015-01-01T00:00:00Z